Impact of proton pump inhibitors on pathologic response rates following fluoropyrimidine-based neoadjuvant chemotherapy in pancreatic cancer patients

Proton pump inhibitors (PPIs) negatively impact fluoropyrimidine-based chemotherapy efficacy in colorectal cancer. This study assessed PPI impact on major pathologic response (mPR) rates of pancreatic adenocarcinoma (PDAC) patients receiving fluoropyrimidine-based chemotherapy. An institutional retr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of surgical oncology 2024-09
Hauptverfasser:	Steadman, Jessica A, Sultan, Ahmer, Day, Courtney N, Parish, Marie A, Warner, Susanne G, Kendrick, Michael L, Truty, Mark J, Jin, Zhaohui, Thiels, Cornelius A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!